Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"Finished product testing and reference standards material is what you will be seeing a lot more of in the future"......looks like it bodes well for Chromadex....
it sounds to me they are moving up NR to 4thQ from 1stQ..and I think that alone will attract interest..they have said that NR would be the game changer for them..and I think we will hear about their partnership with pteropure..this stock takes patience..I just buy and add and sit back and wait to reap..this is one of those stocks in my opinion..the other thing that I really believe about this company is someone snatching them up before they get bigger..the 2 co-chairs are M&A guys with experience..I think they are there for a reason..
Chromadex, the potential "Game Changer" in Patient Dependency of the Multi-Billion Dollar Pharmaceutical Industry
Read more here: http://www.sacbee.com/2012/11/08/4971555/chromadex-the-potential-game-changer.html#storylink=cpy
not really
they were the ones supplying the ingredients for research on stevia..that whole thing is what put the light bulb on for them in terms of how much of an inside knowledge base they had to see what researchers are working on...and after that they decided to act on that insider knowledge...that is how they got pterostilbene..then they went after the patents and securing it...that is there whole foundation for anything new they have in the pipeline...they patent and licence before anyone else can...this company will come into it's own shortly...if not bought out by a big pharma...they are not going unnoticed...I guarantee you...
I am never one to post theories...I like to stick to the facts but it just seems to me to be unusually quiet...like I posted before not from pr but from other posts..even the ones from chromadex's media company they paid to get the word out about their company...which means that chromadex is also being quiet on that part also...earnings soon so we should hear what has been going on...
could work both ways..with no selling pressure it could creep back up
u are following the wrong person...rain is a trader..he is pumping when he is in and bashing when he is out..notice how no one is selling the stock...it is dormant...not selling off...if u sold when it spiked...good for u...but there are a lot of insiders with lots of $$$$$$ invested in chromadex and a lot of us invested that know what we have here...this is one of those stocks u wish u had been in or not sold...does not mean these traders aren't making money off of it...sure they are...depends on whether u are a trader or an investor...I buy my stocks I know are solid and I don't like to trade...too stressful...
selling has definitely dried up...it seems we are in a holding pattern here..
I guess what I am thinking is why is it so quiet...
for instance small companies pay a promotion company a certain amount of money to get their name out their in the news...not to pump the stock but to pump the company itself and who they are... via it be just repeat stories of the same thing...chromadex also did that...I forget the name of the company they used...and then in return that company pays for articles to be written...that is where u get these compensated articles like on seeking alpha...and when you had no pr from the co. u still saw these articles...
so not seeing pr is normal until they have something to report...
but not seeing any promotion articles that talk about the company all of a sudden after their great results seems strange...
any thoughts appreciated
anyone??what is your take on how quiet it is in the news on cdxc...and I'm not just talking about pr from the co....but no articles or anything...
seems like we are at a stalemate.....
I'm still here...I am not going anywhere
it's just dwindling down on low volume..as soon as news hits it will take off
ChromaDex interview with Patrick Cox..https://vimeo.com/50615533
Curcumin is one of the compounds they are working on right now
maybe something on Cott
Opko's 4KScore Could Generate Over $1.8 Billion Annually
http://seekingalpha.com/article/902221-opko-s-4kscore-could-generate-over-1-8-billion-annually
don't forget Frost's own words... "Other people are investing in the company and I want to align myself with them," said Frost in a phone interview last Thursday with Barron's. "Besides which, I think it's a good investment." Frost said that he's often encountered short sellers when building his businesses. Opko's mix of assets may look complicated, he acknowledged. "But I've never been connected with a company that has so many valuable assets as Opko," Frost said.
and it is really dumb to be shorting at this price..I guarantee you pro shorts shorted this at a much higher price
Opko Health: Setting Up For A Big Short Squeeze? http://finance.yahoo.com/news/opko-health-setting-big-short-111402519.html
I agree..some overlook that fact when insiders exercise options as just being free stock given to them...wake up folks...they exercise them when they KNOW the stock is going up..just like any insider buying
@zagdad...thanks...I found that...
I found it...exercising his options
@madprophet...where did u see that? Honig buys
@zagdad...I don't know how to figure that out but I will tell you that when I talked to investor relations about the new regulations the govt. is imposing...he told me that meant nothing but good things for chromadex...the whole foundation of their business is still their core business...and that the stricter regulations would mean everything being tested which is the business of chromadex...
Jaksch said the BluScience is their way of bringing recognition to the ingredients that they are licensing and patenting...I don't think they ever had an intention to turn their business into a supplement business by what he has said...they want to sell their ingredients...and I believe every ingredient that they run trials on and get the results like they did with pterostilbene just adds real value to the company...
they sell their reference standards and the universities and hospitals are going to be wanting them for their research...they already buy them now...
the supplement co's need the company that set those standards to tests their products
Why Barron’s Article on Opko Health is Myopic....http://www.trefis.com/stock/opk/articles/146298/why-barrons-article-on-opko-health-is-myopic/2012-10-01
OPKO Health Announces Launch of 4Kscore™ in Europe....
http://ih.advfn.com/p.php?pid=nmona&article=54360187&symbol=OPK
@zagdad...it means $$$ in the form of standards testing for supplements...especially with the govt. cracking down hard now...read this article it explains it pretty good...
ChromaDex, Phenomenex team up on testing offerings
The legendary Army football teams of the middle 1940s featured Heisman Trophy winners Doc Blanchard and Glenn Davis, dubbed Mr. Inside and Mr. Outside. Now there’s another complementary pairing: ChromaDex has teamed up with testing equipment manufacturer Phenomenex to provide full field coverage for dietary supplement manufacturers seeking reference standards, scientifically valid methods and application support.
http://www.nutraingredients-usa.com/Industry/ChromaDex-Phenomenex-team-up-on-testing-offerings
Interesting Opportunities In The Vitamin Market....
http://seekingalpha.com/article/892081-interesting-opportunities-in-the-vitamin-market
2012 Aegis Healthcare Conference....
Advence Technology Inc. (ACTC)
Ampio Pharmaceuticals Inc. (AMPE)
AspenBio Pharma (APPY)
AtheroNova Inc. (AHRO)
Bio specifics (BSTC)
Biomerix
Celsion Corp (CLSN)
Chromadex (CDXC)
CytRx Corporation (CYTR)
FlouroPharma Medical (FPMI)
Galectin Therapeutics (GALT)
Galena Biopharma (GALE)
IntelGenx Corporation (IGXT)
Invivo Therapeutics (NVIV)
Lpath Inc. (LPTN)
Neuralstem (CUR)
NovaBay Pharmaceuticals (NBY)
PURE Biosciences (PURE)
Rosetta Genomics (ROSG)
SciClone Pharmaceuticals Inc. (SCLN)
Spectrum Pharmaceuticals, Inc. (SPPI)
Synergy Pharmaceuticals, Inc (SGYP)
Tonix Pharmaceuticals Holding Corp (TNXP)
Trovagene Inc. (TROV)
VentriPoint Diagnostics Ltd. (VPTDF)
just shows you why they need to split and move up to nasdaq...get rid of most of the punk penny traders
it's at the 20dma...maybe that will be support..problem with these low priced stocks is they get so many momentum traders jump on them...
An Analysis of the Investment Success of Dr. Phillip Frost....
Claros...This technology could reduce the need for laboratories and lead to earlier diagnosis of diseases such as Alzheimer’s, Parkinson’s, and Pancreatic and Lung Cancers. Dr. Frost estimates that this diagnostics tool could bring in more than $3.6 billion in annual revenue.
http://www.trefis.com/stock/teva/articles/144709/an-analysis-of-the-investment-success-of-dr-phillip-frost/2012-09-21
I SAID YOUR COMMENT WAS GARBAGE THAT THE STOCK WOULD GO TO .40 OR .50... it wasn't even that low before the results..and you are talking to the wrong person if you think I am mad...I have made a ton of $$$$$ on cdxc...I am done talking with you..you are only here to cause trouble..
@newguy..thanks..I try to post news and I do post my opinion but I always encourage people to do their own DD so they feel good about their investment..and I hate the yahoo mb also but I do post over their mainly to dispute the crap some of them spew over their especially the shorts..I really like the respect everyone has on this mb
@mad...looks like stock could be settling in here @ the 61.8 fib level
@Crazyjake...because Jaksch plan is to move up to the Nasdaq or likes..
We should be hearing something on Cott pretty soon..Jaksch said all Cott was waiting on was the results...for anyone new Cott is the world’s largest private label beverage company